Skip to main content
Top
Published in: Clinical and Experimental Nephrology 2/2007

01-06-2007 | ORIGINAL ARTICLE

Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient

Authors: Enyu Imai, Masaru Horio, Kunitoshi Iseki, Kunihiro Yamagata, Tsuyoshi Watanabe, Shigeko Hara, Nobuyuki Ura, Yutaka Kiyohara, Hideki Hirakata, Toshiki Moriyama, Yasuhiro Ando, Kosaku Nitta, Daijo Inaguma, Ichiei Narita, Hiroyasu Iso, Kenji Wakai, Yoshinari Yasuda, Yusuke Tsukamoto, Sadayoshi Ito, Hirofumi Makino, Akira Hishida, Seiichi Matsuo

Published in: Clinical and Experimental Nephrology | Issue 2/2007

Login to get access
Metadata
Title
Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient
Authors
Enyu Imai
Masaru Horio
Kunitoshi Iseki
Kunihiro Yamagata
Tsuyoshi Watanabe
Shigeko Hara
Nobuyuki Ura
Yutaka Kiyohara
Hideki Hirakata
Toshiki Moriyama
Yasuhiro Ando
Kosaku Nitta
Daijo Inaguma
Ichiei Narita
Hiroyasu Iso
Kenji Wakai
Yoshinari Yasuda
Yusuke Tsukamoto
Sadayoshi Ito
Hirofumi Makino
Akira Hishida
Seiichi Matsuo
Publication date
01-06-2007
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 2/2007
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-007-0463-x

Other articles of this Issue 2/2007

Clinical and Experimental Nephrology 2/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.